Title to Properties and Assets. The Company has good and marketable title to its properties and assets, in each case subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than those resulting from taxes which have not yet become delinquent.
Appears in 3 contracts
Samples: Backstop Commitment Agreement (Iaso Pharma Inc), Subscription Agreement (Iaso Pharma Inc), Subscription Agreement (Iaso Pharma Inc)
Title to Properties and Assets. The Company has good and ------------------------------ marketable title to its properties and assets, assets held in each case subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than those resulting from taxes which have not yet become delinquentcharge of any kind.
Appears in 3 contracts
Samples: Preferred Stock Purchase Agreement (Pericom Semiconductor Corp), Preferred Stock Purchase Agreement (Pericom Semiconductor Corp), Preferred Stock Purchase Agreement (Pericom Semiconductor Corp)
Title to Properties and Assets. The Company has good and marketable ------------------------------ title to its properties and assets, assets held in each case subject to no mortgage, pledge, lienLien, leaseencumbrance, encumbrance security interest or chargecharge of any kind. With respect to the property and assets it leases, the Company is in compliance with such leases and, the Company holds valid leasehold interests in such assets free of any liens, encumbrances, security interests or claims of any party other than those resulting from taxes which have not yet become delinquentthe lessors of such property and assets.
Appears in 2 contracts
Samples: Loan Agreement, Loan Agreement (Hawker Pacific Aerospace)
Title to Properties and Assets. The Company has good and marketable title to, or rights to use, its properties and assets, assets held in each case subject to no mortgage, pledge, lien, leaseencumbrance, encumbrance security interest or chargecharge of any kind, other than those resulting from taxes which have not yet become delinquentexcept for liens in favor of MiniMed or disclosed in the Financial Statements.
Appears in 1 contract
